Shapeshifting capsule is a loss leader

Israel’s Epitomee has completed clinical trials of its ingestible pill that opens up in the stomach to produce a feeling of satiety. In 24 weeks the 140 participants who swallowed the pill lost up to 15% of their body weight, with no side effects.  Epitomee intends to apply for FDA approval in 2024.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *